Literature DB >> 23851905

Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.

Katarzyna Stebelska1.   

Abstract

Psychoactive drugs of fungal origin, psilocin, ibotenic acid, and muscimol among them have been proposed for recreational use and popularized since the 1960s, XX century. Despite their well-documented neurotoxicity, they reached reputation of being safe and nonaddictive. Scientific efforts to find any medical application for these hallucinogens in psychiatry, psychotherapy, and even for religious rituals support are highly controversial. Even if they show any healing potential, their usage in psychotherapy is in some cases inadequate and may additionally harm seriously suffering patients. Hallucinogens are thought to reduce cognitive functions. However, in case of indolealkylamines, such as psilocin, some recent findings suggest their ability to improve perception and mental skills, what would motivate the consumption of "magic mushrooms." The present article offers an opportunity to find out what are the main symptoms of intoxication with mushrooms containing psilocybin/psilocin, muscimol, and ibotenic acid. The progress in analytical methods for detection of them in fungal material, food, and body fluids is reviewed. Findings on the mechanisms of their biologic activity are summarized. Additionally, therapeutic potential of these fungal psychoactive compounds and health risk associated with their abuse are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23851905     DOI: 10.1097/FTD.0b013e31828741a5

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

Review 1.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

2.  Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.

Authors:  Olga Zhuk; Izabela Jasicka-Misiak; Anna Poliwoda; Anastasia Kazakova; Vladlena V Godovan; Marek Halama; Piotr P Wieczorek
Journal:  Toxins (Basel)       Date:  2015-03-27       Impact factor: 4.546

3.  The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat.

Authors:  Lukas Rambousek; Tomas Palenicek; Karel Vales; Ales Stuchlik
Journal:  Front Behav Neurosci       Date:  2014-05-16       Impact factor: 3.558

Review 4.  Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.

Authors:  Jiri Patocka; Ran Wu; Eugenie Nepovimova; Martin Valis; Wenda Wu; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

5.  The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.

Authors:  Daniela Dudysová; Karolina Janků; Michal Šmotek; Elizaveta Saifutdinova; Jana Kopřivová; Jitka Bušková; Bryce Anthony Mander; Martin Brunovský; Peter Zach; Jakub Korčák; Veronika Andrashko; Michaela Viktorinová; Filip Tylš; Anna Bravermanová; Tom Froese; Tomáš Páleníček; Jiří Horáček
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

Review 6.  Human Poisoning from Poisonous Higher Fungi: Focus on Analytical Toxicology and Case Reports in Forensic Toxicology.

Authors:  Estelle Flament; Jérôme Guitton; Jean-Michel Gaulier; Yvan Gaillard
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-11

7.  Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis.

Authors:  Anna Poliwoda; Katarzyna Zielińska; Piotr P Wieczorek
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.